Stockscreener 앱 받기
224.60
1.77%
-4.05
시장 영업 전:
224.21
-0.39
-0.17%
Alnylam Pharmaceuticals Inc 주식(ALNY)의 최신 뉴스
Familial Amyloid Polyneuropathy Market - Future Market Insights
ALNY Looks 56.7% Undervalued on GF Value™ - GuruFocus
Alnylam Pharmaceuticals (ALNY): Investor Outlook With A 62.82% Potential Upside - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Alnylam Pharmaceuticals, Inc. (ALNY) And Encourages Shareholders to Reach Out - ACCESS Newswire
Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Investors to Contact the Firm - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
S&CO Inc. Acquires New Holdings in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
SCS Capital Management LLC Invests $34.78 Million in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Why the Alnylam Sell-Off Looks Overdone -- and What Investors Are Missing - The Motley Fool
Alnylam Pharmaceuticals Is Maintained at Equal-Weight by Wells Fargo - Moomoo
Kessler Topaz Meltzer & Check, LLP Encourages Alnylam - GlobeNewswire
NASDAQ: ALNY Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Investors to Contact the Firm - The AI Journal
ALNY Maintains Equal-Weight by Wells Fargo -- Price Target Lowered to $256 - GuruFocus
Alnylam Pharmaceuticals (NASDAQ:ALNY) Given New $256.00 Price Target at Wells Fargo & Company - MarketBeat
S&P 500 Futures Climb In Premarket Trading; Alnylam Pharmaceuticals, BridgeBio Pharma Lead - Moomoo
Alnylam Pharmaceuticals (ALNY) Cuts Guidance As Undervalued Narrative Faces A Tougher Test - simplywall.st
Stifel Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $318 - Moomoo
Securities Fraud Investigation Into Alnylam - GlobeNewswire
Securities Fraud Investigation Into Alnylam Pharmaceuticals, Inc. (ALNY) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - WBOC TV
Is Alnylam’s Mixed 2026 Guidance Reset Altering The Investment Case For Alny (ALNY)? - simplywall.st
Handelsbanken Fonder AB Sells 29,207 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Drugs that missed the mark in pharma’s last earnings round - Pharma Voice
Alnylam Pharmaceuticals (ALNY) Short Interest & Short Float | Updated Aug 2026 $ALNY - marketbeat.com
$1000 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth This Much Today - benzinga.com
Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Exploring a 71% Potential Upside Amid Strong Revenue Growth - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
PensionDanmark Pensionsforsikringsaktieselskab Sells 12,119 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Pacer Advisors Inc. Sells 5,110 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Assenagon Asset Management S.A. Has $46.87 Million Holdings in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam Pharmaceuticals, Inc. (ALNY) Stock forecasts - Yahoo Finance UK
Research Analysts Offer Predictions for ALNY Q3 Earnings - MarketBeat
ALNYLAM PHARMACEUTICALS INC (1ALNY.MI) stock price, news, quote and history - Yahoo Finance Singapore
Empowered Funds LLC Lowers Stock Position in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam Pharmaceuticals (ALNY) On Lowered TTR Guidance And What It Means For Valuation - simplywall.st
Implied Volatility Surging for Alnylam Pharmaceuticals Stock Options - Yahoo Finance
ALNYLAM INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Truist Financial Issues Pessimistic Forecast for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price - MarketBeat
Securities Fraud Investigation into Alnylam - GlobeNewswire
Alnylam (ALNY) Turns Profitable as Revenue Mix Shifts: What Changes in Its Investment Story? - simplywall.st
Quantinno Capital Management LP Purchases 8,258 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
ALNY Investors Have Opportunity to Join Alnylam Pharmaceuticals, Inc. Fraud Investigation with SBS Law - Business Wire
Barclays Lowers Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $450.00 - MarketBeat
Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: 87.96% Potential Upside Beckons Investors - DirectorsTalk Interviews
ALNYLAM PHARMACEUTICALS INC : RAYMOND JAMES CUTS TARGET PRICE TO $420 FROM $468 - webull.com
Cetera Investment Advisers Has $7.67 Million Stake in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam Pharmaceuticals (NASDAQ:ALNY): Affordable Growth at a Reasonable Valuation - ChartMill
Alnylam (ALNY) Stock Stalls As TTR Sales Top $1b And Guidance Tightens - simplywall.st
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Lowered to $350.00 at Oppenheimer - MarketBeat
Alnylam Pharmaceuticals, Inc. (ALNY) Stock Forecasts - finance.yahoo.com
Alnylam Earnings: Shares Tank Amid Reduced Outlook for Key ATTR Franchise - Morningstar
Alnylam Pharmaceuticals Inc (ALNY) (Q2 2026) Earnings Call Highl - GuruFocus
Alnylam: Q2 Earnings Snapshot - king5.com
Alnylam (ALNY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Alnylam Pharmaceuticals (ALNY) Could Be 34% Undervalued After Alzheimer’s Pipeline Update - Yahoo Finance
Unlocking Q2 Potential of Alnylam (ALNY): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
Why Alnylam’s Best Quarter Ever Didn’t Come With a Richer Valuation - Yahoo Finance
Dimensional Fund Advisors LP Purchases 82,340 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Did Alnylam’s Alzheimer’s Pipeline Advances Just Shift Alnylam Pharmaceuticals' (ALNY) Investment Narrative? - simplywall.st
Alnylam Rises as Investors Weigh Pipeline Momentum, Earnings Setup, and ATTR-CM Positioning - Quiver Quantitative
Alnylam Pharmaceuticals Inc (ALNY) Institutional Confidence - TradingKey
Alnylam Pharmaceuticals Inc (ALNY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alnylam Pharmaceuticals (ALNY) Could Be 38% Undervalued After Mivelsiran Trial Progress - simplywall.st
BR:A1LN34 Stock Latest News - TipRanks
Alnylam Pharmaceuticals, Inc. (ALNY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Alnylam Pharmaceuticals Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com
3.70%
자본화:
|
볼륨(24시간):